ISHIBASHI MICHIO has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are BF ESSE SIA, AROG PHARMACEUTICALS LLC and LDN PHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Japan | 2 | |
#5 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Specific use of cosmetics | |
#5 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Ishibashi Michio | 13 |
#2 | Wagner Alain | 3 |
#3 | Mioskowski Charles | 3 |
#4 | Sylvain Catherine | 3 |
Publication | Filing date | Title |
---|---|---|
WO2008133036A1 | Method for screening of therapeutic agent for renal tubular dysfunction | |
JP2009178052A | Method for screening compound for preventing, mitigating or treating pancreatic islet lesion of pancreas | |
JP2009126822A | Pharmaceutical composition for preventing, mitigating or treating renal glomerular lesion | |
WO2007142309A1 | Method of screening drug for treating kidney glomerulus | |
EP1950563A2 | Method for screening for a substance for promoting regeneration of macrophages | |
WO0172730A1 | Selective preventives/remedies for progressive lesions after organ damage |